We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.82B
AUM Growth
+$786M
Cap. Flow
+$219M
Cap. Flow %
3.76%
Top 10 Hldgs %
35.53%
Holding
313
New
38
Increased
59
Reduced
159
Closed
42

Top Buys

Rank Stock Value
1
APA icon
APA Corp
APA
+$107M
2
ALGN icon
Align Technology
ALGN
+$80.9M
3
LITE icon
Lumentum
LITE
+$68.1M
4
ATVI
Activision Blizzard
ATVI
+$48.8M
5
AMED
Amedisys
AMED
+$44.7M

Top Sells

Rank Stock Value
1
N
Netsuite Inc
N
+$71.5M
2
SBUX icon
Starbucks
SBUX
+$52.8M
3
CRAY
Cray, Inc.
CRAY
+$49.5M
4
SAVE
Spirit Airlines, Inc.
SAVE
+$42.6M
5
BIDU icon
Baidu
BIDU
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 22.25%
2 Consumer Discretionary 20.56%
3 Healthcare 18.35%
4 Communication Services 17.97%
5 Miscellaneous 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCE
176
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$690K 0.01%
11,495
-3
-0% -$173
MELI icon
177
Mercado Libre
MELI
$93.5B
$643K 0.01%
3,477
-32
-0.9% -$5.3K
CONN
178
DELISTED
Conn's Inc.
CONN
$614K 0.01%
+59,469
New +$467K
P
179
DELISTED
Pandora Media Inc
P
$610K 0.01%
42,555
-9,508
-18% -$128K
NPTN
180
DELISTED
NEOPHOTONICS CORP
NPTN
$523K 0.01%
+31,991
New +$450K
JD icon
181
JD.com
JD
$36.7B
$516K 0.01%
19,765
+13,125
+198% +$316K
CRBP icon
182
Corbus Pharmaceuticals
CRBP
$124M
$508K 0.01%
+2,495
New +$310K
RARE icon
183
Ultragenyx Pharmaceutical
RARE
$1.29B
$485K 0.01%
6,840
-2
-0% -$128
ELLI
184
DELISTED
Ellie Mae Inc
ELLI
$460K 0.01%
4,372
+1,436
+49% +$139K
TTD icon
185
Trade Desk
TTD
$7.03B
$446K 0.01%
+152,740
New +$451K
RUN icon
186
Sunrun
RUN
$2.02B
$429K 0.01%
68,146
-1,091
-2% -$6.11K
IBM icon
187
IBM
IBM
$234B
$408K 0.01%
2,684
-2,191
-45% -$332K
NTRA icon
188
Natera
NTRA
$49.6B
$355K 0.01%
+31,933
New +$360K
ZTS icon
189
Zoetis
ZTS
$30.4B
$355K 0.01%
6,819
+89
+1% +$4.5K
NWHM
190
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$346K 0.01%
32,441
-859
-3% -$8.57K
WBA
191
DELISTED
Walgreens Boots Alliance
WBA
$340K 0.01%
4,221
-589
-12% -$48K
GILD icon
192
Gilead Sciences
GILD
$180B
$337K 0.01%
4,257
SHW icon
193
Sherwin-Williams
SHW
$78.1B
$303K 0.01%
3,291
+1,434
+77% +$139K
ETSY icon
194
Etsy
ETSY
$6.77B
$292K 0.01%
20,474
-2,770
-12% -$35.1K
APYX icon
195
Apyx Medical
APYX
$123M
$276K ﹤0.01%
+52,995
New +$172K
NBLX
196
DELISTED
Noble Midstream Partners LP
NBLX
$275K ﹤0.01%
+9,847
New +$265K
FBK icon
197
FB Financial Corp
FBK
$2.76B
$264K ﹤0.01%
+13,087
New +$269K
CCOI icon
198
Cogent Communications
CCOI
$462M
$261K ﹤0.01%
7,090
+3,544
+100% +$137K
BOX icon
199
Box
BOX
$4.8B
$257K ﹤0.01%
16,319
TMUS icon
200
T-Mobile US
TMUS
$195B
$229K ﹤0.01%
4,904
+1,825
+59% +$83.8K

Similar funds

Gilder Gagnon Howe & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Gilder Gagnon Howe & Co held 313 positions worth $5.82B, up 16% from $5.03B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Gilder Gagnon Howe & Co deployed $219M of net new capital in Q3 2016, opening 38 new positions and adding to 59 existing holdings. Its largest new stake was APA Corp: 1,953,545 shares worth $125M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Starbucks, an estimated $52.8M trimmed.

  • Gilder Gagnon Howe & Co's largest Q3 2016 buy was APA Corp: 1,953,545 shares worth $125M.
  • Gilder Gagnon Howe & Co added most to Align Technology in Q3 2016, an estimated $80.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2016 reduction was Starbucks, cutting an estimated $52.8M.
  • Gilder Gagnon Howe & Co fully exited Netsuite Inc in Q3 2016, selling an estimated $71.5M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $5.82B portfolio in Q3 2016.
  • Gilder Gagnon Howe & Co opened 38 new positions and closed 42 in Q3 2016.
  • Gilder Gagnon Howe & Co's portfolio value rose 16% quarter-over-quarter to $5.82B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2016, filed 1 Nov 2016.